David Luther joined Mission Therapeutics in 2015 as the Chief Financial Officer.

Mr. Luther brings more than 25 years of financial and operational experience, across the pharmaceutical and Fast-Moving Consumer Goods (FMCG) industries.

Prior to joining Mission Therapeutics, David worked as VP Finance in the UK, Ireland and Italy at the Spotless Group, a private equity backed FMCG business, where he assisted in completing a trade exit to Henkel. Prior to this, Mr Luther was Finance Director for the Italian operations of Aptuit, a global healthcare contract services organisation. Prior to Aptuit, David spent 15 years at GlaxoSmithKline (GSK), where he held a number of senior roles. These included Director, Corporate Development, responsible for M&A transactions, Finance Director Neurosciences R&D, plus several Finance Director roles in international markets.

David trained and qualified as an ACA with KPMG and has a BSc in Biochemistry from the University of Surrey, UK.